The Race to Become Superhuman

Up until fairly recently, medicine essentially involved smearing various unmentionable items all over ourselves in an attempt to cure invisible ailments.

Ground up corpses, animal blood and liquid mercury were tools of the medical trade for centuries. And using lizard blood, dead mice and mouldy bread as topical ointments was common practice.

In 5000BC, if you came in complaining of a headache, chances are your skull would be hacked at with a crude excuse for an ice-pick to remove the ‘bad blood’ making you sick. It took us a while to work out that this practice, called ‘trepanation’, probably added to the problem rather than cured it.

But hey, we did our best.

To be fair, we were faced with an impossibly difficult, and wholly malevolent force. Good people were dying of horrible illnesses we couldn’t understand. So instead of perceiving illnesses as natural phenomenon, cancer and all other diseases were deemed to be caused by the will of the Gods.

For example, if you fell ill in ancient Babylon, it was assumed that your suffering was punishment from the gods for your past misdeeds. And as such, it was common for a doctor to proscribe sleeping with a human skull for a week to exorcise any demons housed within your body.

The same was true in 2nd Century China, where liquid mercury, or ‘quicksilver’, was ingested in the hopes of curing disease and becoming immortal. Sadly, as we now know, mercury isn’t exactly known for its life-giving properties.

Other times, medical treatment was just the result of half-baked reasoning. In 17th century England for example, King Charles II allegedly enjoyed a draught of ‘King’s Drops’, a restorative brew made from crumbled human skull and alcohol. And the ancient Romans were convinced that drinking the blood of fallen gladiators could cure epilepsy and increase vitality.

You can sort of see what they were going for here, but again, they missed the mark.

Looking at all of these weird and wonderful treatments, it’s evident that medicine truly came from humble beginnings. Nowadays, we have moved from ignorance to enlightenment, and have incredibly sophisticated treatments available to people suffering from aggressively complex illnesses.

But, despite lack of trying, there are still some diseases that we just can’t seem to defeat.

Leaping away from death

Chances are, within your lifetime, you’ll get cancer.

According to the Cancer Council Australia, it is expected that 1 in 2 Australians will be diagnosed with cancer by the age of 85. And 134,172 new cases of cancer will be diagnosed in Australia this year alone.

Cancer is ‘The Emperor of All Maladies’, as author and oncologist Siddhartha Mukherjee puts it in his best selling book of the same name. It is the be-all and end-all disease, and has the potential to destroy you from the inside out. It wreaks havoc indiscriminately — taking the lives of young and old alike — leaving broken families in its wake.

Of course, the best way to treat cancer is to prevent it from occurring. So giving up smoking, and keeping a healthy diet, are the single most effective ways to prevent cancer.

Because once cancer does manifest, that’s where it gets tricky. Chemotherapy can only do so much, as it’s non-targeted and destroys any fast dividing cells, whether they’re cancerous or not. So even after going through the gruelling process of what is essentially ingesting poison, in the hopes of destroying mutated cells, you could be left worse off than you started.

But what if we could target those cells specifically?

In his new research report, Harje Ronngard has found something called the ‘Living Drug’. 

What makes this treatment different is that it doesn’t treat the disease itself. Instead, it supercharges your immune system by re-engineering your own T-cells, and allows them to defeat the disease autonomously.

As Harje explained in Markets & Money on Tuesday:

The first step involves drawing blood.

Doctors separate the T cells. Once in the lab, researchers introduce specific proteins, which are found in specific cancer cells. The T cells are engineered to then find cells with a particular protein and kill them.

Once engineered, researchers grow these T cells into hundreds of millions. The final step is to pump this living drug back into the patient.

If all goes well, the engineered cells will multiple rid the patient of all cancerous cells.’

Big pharma is already throwing billions at this discovery to get it on pharmacy shelves, and into the hands of those that need it most. This ground breaking drug has already been proven to save lives and could eventually be as common place and as profitable as Penicillin.

Now, when you’re taking about something like cancer, it’s difficult to launch into how much money you can make from a new treatment without sounding somewhat…insensitive.

But in his new report, it’s easy to see that Harje truly believes this new ‘Living Drug’ is truly destined for greatness. He painstakingly outlines how it will benefit those who previously had no hope, and how it could revolutionise cancer treatment worldwide. Which is why he wants investors to get behind it, both to advance the future of medicine, and to benefit themselves.

With that said, Harje believes early investors could potentially grab a gain of 2,422%. And all the while they could be part of one of the biggest medical revolutions of all time.

To read his full research report, and to learn more about the incredible potential of the ‘Living Drug’, click here.

This week in Markets & Money:

Australia’s property prices are in decline — and the trend is only continuing. Property value and rent prices are declining, auction rates have dropped, and more listings are becoming available — and with construction still going strong, there is even more supply to hit the market yet. But despite the long-overdue drop, is this good news? Read the full story from Monday here.

Humans are living longer and healthier. But despite the continuous scientific breakthroughs, it is highly likely that tomorrow’s workforce will have to work longer to afford retirement. And with scientists now approaching aging as an illness that could also be cured, who knows when we’ll see retirement? Read the full story here.

The US job market is expanding, and wage growth could soon be on the rise. Interest rates could be ready for a spike, and inflation is at its highest rate since 2012. With such trends appearing, the question now becomes, what could high inflation in the US mean for the global economy? Find out how to protect yourself from the mother of all inflations here.

PayPal co-founder Peter Thiel is passionate about extend human lifespans. He recently poured cash into the Methuselah Foundation — a project looking to turn 90-year-olds into healthy and energetic 50-year-olds by 2030. And they’re not the only ones running the race — tech giants such as Google are using their power to tap into the market of healthcare. ‘Living forever’ may be a reality not so far away….read the full report here.

On Friday, Harje explained why small businesses often have an advantage over big behemoth companies. Particularly when it comes to small biotech firms. There’s one tiny biotech stock in particular that could be set to revolutionise cancer treatment and your portfolio at the same time! To find out more, click here.

Until next week,

Katie Johnson,
Editor, Markets & Money


Katherine Johnson, usually going by just ‘Katie’, is a member of Port Phillip Publishing’s editorial team, as well as the Editor of the Saturday edition of Markets & Money. Katie works with all of your editors to maintain the quality of their research and analysis. In her Saturday Markets & Money articles she specialises in cryptocurrency and technology stories, and brings you a recap of the week from your other Markets and Money editors.


Leave a Reply

Your email address will not be published. Required fields are marked *

Markets & Money